Kevin D. Bunker, Chief Operating Officer at Zentalis Pharmaceuticals, Inc. (ZNTL), sold 16,000 shares at $46.23 ($754K) on 2022-03-10, disclosed to the SEC on 2022-03-10.
Open-market sale of $754k ZNTL by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $46.23 | 4,000 | $185K | 24.5% |
| 2 | $47.18 | 4,301 | $203K | 26.9% |
| 3 | $47.18 | 4,301 | $203K | 26.9% |
| 4 | $47.99 | 1,699 | $82K | 10.8% |
| 5 | $47.99 | 1,699 | $82K | 10.8% |
| Total | $47.11 avg | 16,000 |
| $754K |
| 100% |
| Filing → |
| ZNTL | SELL | 2023-02-14 | $285K | — | Filing → |
| ZNTL | SELL | 2022-08-12 | $150K | — | Filing → |
| ZNTL | SELL | 2022-07-20 | $150K | — | Filing → |